Ben Goodwin, co-founder and CEO of OLIPOP, built a $1.8 billion beverage company by doing something the industry's giants stopped doing decades ago: formulating every product himself, in his own lab, without outsourcing to a flavor house.
Goodwin launched OLIPOP in 2018. The brand positions itself as a functional soda—a prebiotic drink engineered with fiber, prebiotics and Stevia to support gut health while delivering the nostalgic taste of classic sodas and root beers. Prebiotics are non-digestible fibers that feed beneficial bacteria already in the gut, distinct from probiotics, which introduce live bacteria directly.
The beverage industry is notoriously difficult to enter. Only 0.4 percent of beverage brands ever reach $10 million in annual revenue. High distribution costs and thin margins eliminate most entrants before they scale. OLIPOP crossed that threshold and doubled sales year over year.
Goodwin's product philosophy centers on what he calls authentic nostalgia. The brand deliberately draws on the emotional memory consumers have with traditional soda—the birthday parties, the family gatherings—without dismissing that attachment. OLIPOP celebrates that history rather than shames it, a framing that drives marketing across every channel.
The hands-on formulation approach is rare at $1.8 billion. Major beverage companies contract flavor development to large third-party houses, which creates distance between leadership and the product. Goodwin has maintained direct control over what goes into each can as the company has grown, a structural choice that affects quality consistency as distribution expands.
Goodwin did not arrive at OLIPOP without setbacks. He launched the company after earlier ventures failed. Rather than exit the industry, he refined his approach and launched OLIPOP in 2018.
The competitive backdrop is significant. Coca-Cola and PepsiCo together control the dominant share of the global carbonated soft drink market, backed by distribution networks, marketing budgets and shelf-space relationships built over decades. OLIPOP's entry required convincing retailers to allocate space to an unproven category—functional soda—that had no proven consumer base at launch.
Consumer behavior has moved in OLIPOP's direction. Demand for lower-sugar beverages and products with functional health claims has grown, pulling consumers away from traditional full-sugar sodas. OLIPOP's formulation sits directly in that shift and has sustained year-over-year sales growth on that tailwind.
The scaling challenge now is maintaining product integrity while volume increases. Goodwin's model depends on his personal involvement in formulation. As the company expands SKUs and production volume, the question becomes whether that hands-on standard holds. Brands that grow quickly frequently sacrifice the quality controls that drove early loyalty. For investors, that tension between growth and quality control is the operational test that determines whether OLIPOP's valuation premium holds.
OLIPOP remains private at $1.8 billion. No public offering timeline has been announced, meaning equity access is limited to private markets.
